Brookfield Corporation (BN.TO)
| Previous close | 60.53 |
| Open | 60.96 |
| Bid | 60.82 x N/A |
| Ask | 60.84 x N/A |
| Day's range | 60.53 - 61.36 |
| 52-week range | 40.07 - 61.60 |
| Volume | |
| Avg. volume | 1,698,562 |
| Market cap | 91.724B |
| Beta (5Y monthly) | 1.69 |
| PE ratio (TTM) | 74.18 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.44 (0.72%) |
| Ex-dividend date | 12 Jun 2024 |
| 1y target est | N/A |
- Yahoo Finance
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
- Simply Wall St.
The five-year decline in earnings might be taking its toll on Brookfield (TSE:BN) shareholders as stock falls 4.1% over the past week
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...
- Sky News
Center Parcs owner in talks with new investors over stake sale
The owner of Center Parcs' operations in Britain is in talks with some of its own investors about the sale of a stake in the holiday resorts chain amid a stuttering £5bn auction. Sky News has learnt that Brookfield Property Partners, which has owned the business since 2015, has opened discussions with a number of the limited partners in its funds about a potential transaction. The talks are understood to be at a preliminary stage, and may not lead to a deal, a City source said on Friday, while the identity of the Brookfield LPs was unclear.
